Skip to main navigation

Vor Biopharma

Menu

Bar

Bar

Our Approach
Focus & Pipeline
About Us
Investors
Join Us

News Releases

Year

November 29, 2021

Vor to Participate in the JMP Securities Hematology and Oncology Summit

Read More

November 19, 2021

Vor to Participate in Piper Sandler 33rd Virtual Annual Healthcare Conference

Read More

November 10, 2021

Vor Reports Third Quarter 2021 Financial Results and Provides Company Update

Read More

November 9, 2021

Vor to Present New Data on its Cell and Genome Engineering Platform at SITC Annual Meeting

Read More

November 8, 2021

Vor to Participate in Two Upcoming Investor Conferences

Read More

November 4, 2021

Vor to Present New Platform and Preclinical Data at ASH

Read More

October 19, 2021

Vor to Present Data from its Novel Cell and Genome Engineering Platform at ESGCT

Read More

October 12, 2021

Vor Strengthens Leadership Team with Addition of Dr. Veit Schmelmer as SVP of Program and Alliance Management

Read More

September 9, 2021

VOR33 Granted U.S. FDA Fast Track Designation for AML

Read More

September 2, 2021

Vor to Participate in Three Upcoming Investor Conferences

Read More

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 24

Shareholder Tools

Print Page

RSS

Email Alerts

Contact IR

Search

100 Cambridgepark Dr, Suite 400, Cambridge, MA 02140

P: 617-655-6580

Email

Contact Us
Privacy Policy
Terms of Use

© 2021 Vor Biopharma. All rights reserved.